Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Graves Disease: early-phase trial registry
9 of 12 indexed Graves Disease trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #1,429 of 28,707 conditions by registered trial count.
12 US clinical trials · 9 currently recruiting · #1,429 of 28,707 conditions by registered trial count
Graves Disease: 12 US clinical trials tracked, 9 recruiting.
Graves Disease is the subject of 12 registered US clinical trials on ClinicalTrials.gov, 9 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 7 in Phase 1-2 (earlier-stage). The most active sponsor is Immunovant Sciences, running 2 of these trials.
Enrollment posture brief
Registry condition graves-disease
OPEN 9 | RECR 75% | LATE 1 | EARLY 7 | RANK #1429 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Activity, Motor (75% recruiting · 8 trials)
Graves Disease lists 9 open slots (75% of 12 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Graves Disease on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Graves Disease is recruiting above its size-band peers.
9 of 12 indexed trials (75%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Graves Disease research.
Immunovant Sciences accounts for 2 of 12 trials (16.7%). 11 distinct sponsors appear on at least one study for this condition label.
-
Typical Graves Disease enrolment sits around 93 participants.
Median target enrolment is 93 among the 12 trials that report a genuine target (sentinel values excluded). 7 of those (58.3%) plan for fewer than 100 participants.
-
Graves Disease research is mostly interventional.
10 interventional and 2 observational studies make up this index (83.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
12 total, page 1 of 1
Natural History of Thyroid Function Disorders
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NCT00001159
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
Immunovant Sciences
NCT06727604
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
Immunovant Sciences
NCT07018323
NEXUS Study: A Study to Test Single and Multiple Doses of MER511 Given to Adults With Graves' Disease
Merida Biosciences
NCT07305818
The Effect of Teprotumumab on Thyroid Eye Disease and Thyroid Dysfunction
Walter Reed National Military Medical Center
NCT06275373
Preoperative Corticosteroids in Autoimmune Thyroid Disease
Indiana University
NCT05435547
Impact of Vitamin D Therapy on Thyroid Function and Antibody Levels in Pediatric Graves' Disease
Northwell Health
NCT07369063
Study of BHV-1300 in Graves' Disease
Biohaven Therapeutics
NCT06980649
Personalized Treatment in Thyroid Disorders
Johns Hopkins University
NCT03517579
Shared Decision Making in Graves Disease - Graves Disease (GD) Choice
Mayo Clinic
NCT02107794
Radioactive Iodide Therapy for Pediatric Graves' Disease
University of Florida
NCT01269749
A Study to Evaluate the Safety and Effect of CFZ533 on Patients With Graves' Disease
Novartis Pharmaceuticals
NCT02713256
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 5 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Graves Disease records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Graves Disease trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Graves Disease page
12 registered trials, 9 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 9 Graves Disease trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Immunovant Sciences sponsors the most Graves Disease trials on record, review their full trial history before evaluating a specific study. See Immunovant Sciences's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Graves Disease condition card totals 12 registered trials; most-linked intervention Placebo; top US site state Florida. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.